The Usefulness of CYFRA 21-1 in Diagnosing and Monitoring Malignant Pleural Mesothelioma

Acta Medica Okayama

Volumn 52, Issue 2, 1998, Pages 119-123

  Marukawa, Masaomi ^a   Hiyama, Jyunichiro ^a   Shiota, Yutaro ^a   Ono, Tetsuya ^a   Sasaki, Naomi ^a   Taniyama, Kiyomi ^a   Mashiba, Hiroto ^a  

^a Kure Kyosai Hospital   (Japan)

Author keywords

CYFRA 21 1; Malignant pleural mesothelioma; Tumor marker

Indexed keywords

ANTIBODY; ANTIGEN CYFRA21.1; KERATIN; TUMOR ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; MESOTHELIOMA; PATHOLOGY; PLEURA TUMOR; THORAX RADIOGRAPHY;

AGED; ANTIBODIES; ANTIGENS, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; RADIOGRAPHY, THORACIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0032043212     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Rusch VW: Clinical features and current treatment of diffuse malignant pleural mesothelioma. Lung Cancer (1995) 12, Suppl. 2, 127-146.
2. Pettersson T, Froseth B, Riska H and Klockars M: Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest (1988) 94, 1037-1039.
3. Dahl IM and Laurent TC: Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer (1988) 62, 326-330.
4. Hillerdal G, Lindqvist U and Engstrom-Laurent A: Hyaluronan in pleural effusions and in serum. Cancer (1990) 67, 2410-2414.
5. Blobel GA, Moll R, Franke WW, Kayser KW and Gould VE: The intermediate filament cytoskeleton of malignant mesothelioma and its diagnostic significance. Am J Pathol (1985) 121, 235-247.
6. Suzuki Y: Diagnostic criteria for human diffuse malignant mesothelioma. Acta Pathol Jpn (1992) 42, 767-786.
7. Bolen JW, Hammar SP and Mcnutt MA: Reactive and neoplastic tissue: A light-microscopic, ultrastructural and immunocytochemical study. Am J Surg Pathol (1986) 10, 34-47.
8. Bodenmuller H, Banauch D, Ofenloch B, Jaworek D and Dessaer A: Technical evaluation of a new automated tumor marker assay. The Enzymun-Test CYFRA 21-1; in Tumor Associated Antigens, Oncogenes, Receptors, Cytokines in Tumor Diagnosis and Therapy at the Beginning of the 90th, Klapdor R ed, Zuckschwerdt, Munchen (1992) pp 137-138.
9. Cooper D, Schermer A and Sun TT: Biology of disease: Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations. Lab Invest (1985) 52, 243-256.
10. Rastel D, Ramaioli A, Cornillie F and Thirion B on behalf of the CYFRA 21-1 Multicentre Study Group: CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer: Report of the first European multicentre evaluation. Eur J Cancer (1994) 30, 601-606.
11. Taniyama K, Sasaki N, Wada S, Sasaki M, Miyoshi N, Nakai H, Kodama S, Nakatsuka H and Tahara E: Comparison of proliferative activities and metastases between two subtypes classified at the deeply infiltrating sites of colorectal moderately differentiated adenocarcinomas. Pathol Int (1996) 46, 195-203.
12. Nanba K, Aoki J and Sasaki N: A new enzyme immunohistochemical technique using alkaline phosphatase-labeled avidin and new fuchsin. Byori to Rinsho (1987) 5, 333-339 (in Japanese with English abstract).
13. Moll R, Franke WW, Schiller DL, Geiger B and Krepler R: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 31, 11-24.
14. Wu YJ, Parker LM, Binder NE, Beckett MA, Sinard JH, Griffiths CT and Rheinwald JG: The mesothelial keratins: A new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell (1982) 31, 693-703.
15. LaRocca PJ and Rheinwald JG: Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res (1984) 44, 2991-2999.
16. Pujol JL, Grenier J, Daures JP, Daver A, Pujol H and Michel FB: Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res (1993) 53, 61-66.